ReviewUpdates in surgery2026
Two decades of artificial intelligence in colon cancer diagnosis and treatment: a bibliometric analysis of research trends (2003-2023).
Review in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Broadening the evaluation of AI tools in medical education: beyond ChatGPT-5 toward multi-model and open-source LLM assessment.Updates in surgery · 2026Article
- Molecular Targeting of EGFR, BRAF, and HER2 Signaling in Colorectal Cancer: Contemporary Advances with Panitumumab, Encorafenib, and Tucatinib.Journal of clinical medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
This study aims to analyse research trends, identify key areas of focus, and explore developmental patterns in AI applications for colon cancer diagnosis and treatment from 2003 to 2023. A systematic search of the Web of Science Core Collection database was conducted to identify relevant studies. Bibliometric analysis was performed using VOSviewer to visualize collaborations among countries (regions), institutions, and authors, as well as author cocitations, keyword co-occurrences, and overlay analyses. CiteSpace enabled institutional betweenness centrality analysis, journal dual-map overlay analysis, cluster analysis of cocited literature from the past five years, timeline visualization of cocited literature clusters, and burst detection analysis of references. Microsoft Excel was used to create bar charts of publication volumes and descriptive analysis tables for countries (regions), institutions, journals, authors, cocited authors, cited references, and keywords. The analysis included 1456 publications, revealing a consistent upwards trend in annual publication volume from 2003 to 2023, with a sharp increase from 2020 and a peak in 2023. China was the most productive country (region), the Chinese Academy of Sciences the leading institution, and Mori Yuichi et al. the leading author. Jemal A, Siegel RL, and Kather JN were identified as the most influential researchers based on cocitation analysis. Cancers published the most articles, while Gastroenterology received the highest number of cocitations. Citing journals focused predominantly on the “Molecular, Biology, Immunology” and “Medicine, Medical, Clinical” domains, while cited journals focused on the “Molecular, Biology, Genetics” and “Health, Nursing, Medicine” fields. The most frequently cocited reference was Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Keyword clustering revealed four main research areas: AI-assisted treatment and prognosis prediction, endoscopic diagnosis, pathological diagnosis, and biological research in colon cancer. Current research hotspots include deep learning, convolutional neural networks, radiomics, gastrointestinal endoscopy, pathology, and immunotherapy. This bibliometric analysis highlights the expanding role of AI in colon cancer research, with growing interest from the scientific community. AI applications span various aspects of colon cancer management, including biology, diagnosis, staging, efficacy assessment, and prognosis prediction. These findings provide valuable insights for researchers and clinicians working at the intersection of AI and colon cancer.
Indexed as
Identifiers
41604135What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.